Conflicts of interest: none.
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways†
Article first published online: 28 NOV 2012
Copyright © 2012 Wiley Periodicals, Inc.
Volume 73, Issue 7, pages 754–762, May 2013
How to Cite
Klink, J. C., Tewari, A. K., Masko, E. M., Antonelli, J., Febbo, P. G., Cohen, P., Dewhirst, M. W., Pizzo, S. V. and Freedland, S. J. (2013), Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. Prostate, 73: 754–762. doi: 10.1002/pros.22619
- Issue published online: 15 APR 2013
- Article first published online: 28 NOV 2012
- Manuscript Accepted: 17 OCT 2012
- Manuscript Received: 9 SEP 2012
- NIH. Grant Number: R01 CA131235
Additional supporting information may be found in the online version of this article.
|pros_22619_sm_SupplFig1.tif||1340K||Supplemental Figure 1. Mouse survival in the exploratory study|
|pros_22619_sm_SupplFig2.tif||3384K||Supplemental Figure 2. Median tumor volume in the LAPC4 study|
|pros_22619_sm_SupplFig3.tif||2364K||Supplemental Figure 3. Median tumor volume in the LNCaP study|
|pros_22619_sm_SupplTab1.doc||31K||Supplementary Table 1|
|pros_22619_sm_SupplTab2.doc||29K||Supplementary Table 2|